Role of γδ T Lymphocytes in Cancer Immunosurveillance and Immunotherapy
- 14 November 2014
- book chapter
- Published by Springer Nature
- p. 231-262
Abstract
No abstract availableKeywords
This publication has 250 references indexed in Scilit:
- Body-barrier surveillance by epidermal γδ TCRsNature Immunology, 2012
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumoursBritish Journal of Cancer, 2011
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinomaCancer Immunology, Immunotherapy, 2011
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆European Journal of Cardio-Thoracic Surgery, 2010
- T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor ImmunityImmunity, 2009
- Adoptively transferred ex vivo expanded γδ-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancerBreast Cancer Research and Treatment, 2009
- Interferon‐γ down‐regulates NKG2D ligand expression and impairs the NKG2D‐mediated cytolysis of MHC class I‐deficient melanoma by natural killer cellsInternational Journal of Cancer, 2009
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine, 2008
- An autonomous CDR3δ is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by γδ T cellsNature Immunology, 2008
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008